Artificial Intelligence will have real value in sepsis treatment

I tend to be skeptical of claims that AI is going to lead to big breakthroughs in medicine. Drug discovery is the usual arena for such claims, the notion being that algorithms will pick over drug datasets to open a pipeline of new therapeutics. I’m pretty confident that AI plays will not revolutionize drug discovery.  Read More …

Are investors overvaluing AI in drug discovery?

Business Insider: AI Startup Valued at $2B Probably. After all, most ventures fail. Tech investors, like bidders at an auction, are subject to the Winner’s Curse: those who err on the side of too much optimism are willing to pay more than those who calculate the risk/reward ratio correctly. They win the auction by overpaying. From Read More …